Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Hersenstichting verwacht forse stijging aantal hersenpatiënten door coronavirus
apr 2020